The University of Rochester Medical Center (URMC) has resumed all surgeries, including elective procedures, following delays ...

NINER Pharmaceutical, a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American markets to address critical shortages of IV fluids. Responding to ...

A recent survey by Sensormatic Solutions reveals key insights that can guide both shoppers and retailers during this busy time. According to the survey, 52% of respondents plan to start their holiday ...

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

According to FDA, Hurricane Helen caused a supply disruption of IV solutions from Baxter’s facility in North Carolina.

ICU Medical (ICUI) and Otsuka are launching a joint venture focused on boosting IV solutions production and development in North America. Read more here.

Doctors say they've been forced to ration care as sourcing the essential medicine continues to prove a challenge.

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...